Revolutionizing Cellular Communication with CRISPR and CIBER

The revolutionary CIBER system, developed using CRISPR gene-editing technology, is transforming the study of cell-to-cell communication through small extracellular vesicles (sEVs). These nanosized particles, once considered waste, are now recognized for their significant role in disease propagation and as potential drug carriers. _CIBER_ allows scientists to study thousands of genes concurrently by labeling sEVs with RNA barcodes. This method drastically speeds up and simplifies the analysis of sEV release, surpassing conventional techniques. **CIBER** utilizes CRISPR-guide RNA to selectively incapacitate genes, tracking the resultant sEV release to identify the roles of specific genes. This streamlines the previous labor-intensive process of individually analyzing cell wells and gene interactions. With its potential to identify sEV therapeutic targets or enhance sEV production for treatments, CIBER stands as a promising tool in biological and medical research.